Mesoblast Limited
Level 39
55 Collins Street
Melbourne 3000
AUSTRALIA

+61 3 9639 6036

Email:info@mesoblast.com

For media and shareholder inquiries:

Julie Meldrum
Corporate Communications Director
E: julie.meldrum@mesoblast.com
+ 61 (0) 419 228 128

 

Last Share Price

August 28 - Mesoblast Reports Significant Achievements and Strong Financial Position

August 21 - Mesoblast's Allogeneic "Off -The-Shelf" stem cells are safe and effective for Cervical Spine Fusion

August 12 - Mesoblast's Stem Cells Regrow Knee Cartilage in Severe Post-Menopausal Osteoarthritis

August 07 - Mesoblast - National Electronic Media coverage

May 2008 - Issue Nine

September 2007 - Issue Eight

March 2007 - Issue Seven

August 2006 - Issue Six